Gossamer Bio, Inc. - Common Stock —— 资产负债表 (NASDAQ:GOSS) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 539.43 M343.66 M272.45 M311.92 M315.29 M172.25 M 负债总额 218.75 M222.19 M260.37 M249.15 M285.8 M295.01 M 权益总额 320.68 M121.46 M12.08 M62.77 M29.49 M-122.76 M 负债及股东权益总额 539.43 M343.66 M272.45 M311.92 M315.29 M172.25 M 总债务 28.74 M29.08 M11.99 M814 K0— 净债务 28.74 M29.08 M11.99 M814 K0—

新闻

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates

Regenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates

Kura Oncology (KURA) Reports Q1 Loss, Tops Revenue Estimates

Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Misses Revenue Estimates

CytomX Therapeutics (CTMX) Reports Q1 Loss, Beats Revenue Estimates

Bracing for Stagflation? These 2 Stocks Offer Mouth-Watering Upside - TipRanks.com

Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates

Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - BrainsWay (NASDAQ:BWAY), Definitive Healthcare (NASDAQ:DH)

Alibaba Earnings, Jobs Data

Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates